Please enable JavaScript in your web browser settings, under the site permissions section to unlock full site functionality. Click here for help.

Article Image - OPKO Health Acquires EirGen Pharma

Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Scroll to keep reading

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy

You Might Also Like

Expanding Your Business Through Acquisition Financing

26/04/2024Expanding Your Business Through Acquisition Financing

Expanding a business often entails acquiring another company. This ambitious move, however, requires careful financial planning as well as a deep dive into full standby seller financing and other strategies. For businesses, big or small, pondering an

Emerging Human-Centric Sectors: Why Mental Health and Counseling Skills Are Becoming Business Essentials

22/07/2025Emerging Human-Centric Sectors: Why Mental Health and Counseling Skills Are Becoming Business Essentials

In a time when strategy and innovation rule boardroom discussions, a more subdued change is occurring in all sectors: a move toward goals that are more focused on people. Businesses no longer only concentrate on technology, data, and infrastructure. They are i

Valuation Knows no Boundaries

31/07/2016Valuation Knows no Boundaries

PEM Corporate Finance is an M&A and business valuations firm based in Cambridge, England. We’re part of Kreston International – the 10th largest global network of independent accounting firms. We advise SMEs on M&A, buyouts, business valuations, succession

Can Automation Help to Eradicate Human Error in the Workplace?

27/09/2022Can Automation Help to Eradicate Human Error in the Workplace?

Each day, businesses across the country handle countless transactions and obtain vast amounts of data. Unfortunately, while processing and utilizing this data, the opportunity for human error is high. These mistakes can be costly.

5 Different Aspects of Business Security That Are Often Overlooked (and How to Resolve These in Your Company)

11/12/20235 Different Aspects of Business Security That Are Often Overlooked (and How to Resolve These in Your Company)

Both digital and physical security concerns have to be taken into account, regardless of the size of your business or the industry you operate within. Yet there are all sorts of organizations that either unknowingly overlook or wilfully neglect these mission-c

The Impacts of Corporate Tax Reform III

04/01/2017The Impacts of Corporate Tax Reform III

We are a full-service business law firm. This enables us to render all our services as integrated services across legal areas. Most of our clients are multinational businesses. The firm was established 1911, so we have a history of 105 years now. This makes us

The Importance of IP in M&A transactions

19/11/2015The Importance of IP in M&A transactions

For the past 10 years, Coller IP has been at the forefront of developments in Intangible Asset Management. Jackie Maguire profiles the firm and explains their place in the market.

15/03/2021Preparing your brand for the incoming wave of M&As

Our world is in flux. And although collectively, we are facing many challenges right now, there are myriad opportunities growing in tandem. As many organisations restructure in an effort to weather the current climate, we will inevitably see Europe follow in t

Top Business Events in Frankfurt February 2023 You Should Attend

26/01/2023Top Business Events in Frankfurt February 2023 You Should Attend

In terms of business, Frankfurt occupies one of the central places in all of Europe. Not only do a huge number of businesses open here, but businessmen also come here in search of new partners, deals, and clients. So many people who want to start their busines

View More Articles

Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

MORE BRANDS